PFS was significantly higher in patients who received BCNU wafers (p = 0.008), while OS also favored BCNU use but did not reach statistical significance.
← all excerpts
Carmustine Wafers (Gliadel) in Brain Metastases: Revisiting an Old Concept With New Insights.
1
—
—